Madam Chair, I heard my colleague talk about the need for statistics and monitoring.
I will repeat the suggestions I made in my speech, and I would like to know if he believes that they make sense.
When we talk about monitoring and intervention for overdose prevention and harm reduction, are activities that seek to provide information and raise awareness a good thing in his opinion? Do we need to improve medical and pharmaceutical practices for opioids and pain management? What does he think of access to integrated and adapted services for people receiving treatment for opioid use that requires the use of a drug, as well as training, research and assessment?